Related Experiment Video

Updated: Jul 5, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

Insights into the oncogenic effects of PIK3CA mutations from the structure of p110alpha/p85alpha

Chuan-Hsiang Huang1, Diana Mandelker, Sandra B Gabelli

  • 1Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Cell Cycle (Georgetown, Tex.)
|April 18, 2008
PubMed

Insights

Mutations in PI3Kalpha, a cancer-driving oncogene, often occur at protein interfaces, disrupting interactions and increasing kinase activity. This structural insight offers new targets for developing innovative anti-cancer drugs.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Phosphatidylinositide-3-kinases (PI3K) are crucial signaling enzymes involved in cell growth and survival.
  • The PI3Kalpha isoform is frequently implicated in cancer due to activating mutations.

Purpose of the Study:

  • To elucidate the structural basis of oncogenic mutations in PI3Kalpha.
  • To identify potential drug targets for cancer therapy based on structural findings.

Main Methods:

  • X-ray crystallography to determine the structure of the PI3Kalpha catalytic subunit (p110alpha) complexed with a portion of its regulatory subunit (p85alpha).
  • Analysis of mutation sites within the determined protein structure.

Main Results:

  • The majority of oncogenic mutations in PI3Kalpha are located at the interfaces between p110alpha domains and between p110alpha and p85alpha.
  • These mutations disrupt inter-domain interactions, potentially leading to increased kinase activity.
  • The iSH2 domain of p85alpha is implicated in mediating membrane interactions.

Conclusions:

  • Structural analysis reveals that oncogenic PI3Kalpha mutations cluster at protein-protein interaction interfaces.
  • These findings highlight specific structural regions as potential targets for novel anti-cancer drug design.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.